Investment
Features
FeesSafety
Academy
More
Pluang+

GOP gains lead when promoting capitalism amid booming US economy and strong market.

Market News
05 Aug 2026
Fox Business
View Source
Bullish
GOP gains lead when promoting capitalism amid booming US economy and strong market.

A recent poll shows Republican candidates gain a significant lead over Democrats when clearly supporting free-market capitalism versus socialism. Despite this, Republicans may miss the chance to pass a pro-growth budget with tax and spending cuts. The US economy is currently strong, with manufacturing, AI, construction, consumer spending, and business investment all rising. The stock market is hitting record highs, suggesting a prime opportunity for the GOP to focus messaging on growth and affordability ahead of the midterm elections.

More News

Jyske Bank buys back shares worth DKK 2.15 billion under 2026 repurchase program

Jyske Bank buys back shares worth DKK 2.15 billion under 2026 repurchase program

Jyske Bank has repurchased shares valued at approximately DKK 2.15 billion as part of its ongoing share buyback program running from February 2026 to January 2027. The bank has acquired a total of 2,235,959 treasury shares, representing 3.84% of its ...

Company Fundamentals
Neutral
48 minutes ago
Jyske Bank buys back shares worth DKK 2.15 billion, now holding 3.84% of its capital.

Jyske Bank buys back shares worth DKK 2.15 billion, now holding 3.84% of its capital.

Jyske Bank is conducting a share buyback program from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-October 2026, the bank has repurchased shares worth approximately DKK 2.15 billion at an average price of DK...

Company Fundamentals
Bullish
48 minutes ago
Oculis completes patient randomization in trial for precision treatment of TNFR1-mediated dry eye disease

Oculis completes patient randomization in trial for precision treatment of TNFR1-mediated dry eye disease

Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...

Market News
Bullish
1 hour ago
Ekalia partners with Telix to boost astatine-211 production in the US for cancer therapy.

Ekalia partners with Telix to boost astatine-211 production in the US for cancer therapy.

Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...

Market News
Bullish
2 hours ago
Roche unveils pivotal cancer drug data at ESMO 2026, highlighting advances in lung and breast cancer treatments.

Roche unveils pivotal cancer drug data at ESMO 2026, highlighting advances in lung and breast cancer treatments.

At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App